Table 1.
The protocols of the related drugs to a total of 368 eligible patients in the study.
| Sample | Treatment | Case | |
|---|---|---|---|
| Drugs and dose | size (N) | course (W) | report |
| Celiprolol (200 mg/d) | 54 | 6 | ETW |
| Atenolol (25 mmg/d)/ bisoprolol (5 mmg/d) | 39 | 4 | EQW |
| Doxazosin (2 mmg/d) | 82 | 6 | ETW |
| Azelnidipine (2 mmg/d)/nitrendipine + atenolol (5 + 10 mmg/d) | 73 | 6 | ETW |
| Candesartan (8 mmg/d) + irbesartan (150 mmg/d) | 50 | 6 | ETW |
| Imidapril (5 mmg/d) | 70 | 6 or 8 | ETW or EQW |
N = number; W = week; ETW = every two weeks; EQW = every four weeks.